Letter to the Editor
With interest we read the article by Huang et al. about two siblings carrying both the same compound heterozygous SUCLA2 mutation, which manifested phenotypically with a progressive multisystem syndrome, resulting in severe disability (patient-1) or death (patient-2) [1] . We have the following comments and concerns.
Patient-1 was treated with dichloroacetate (DCA) over at least 4y. DCA is well-known for its neurotoxicity in MELAS patients, resulting in severe polyneuropathy [2] . To which degree was the continuous deterioration of the phenotype attributable to the mitochondrion-toxic effect of DCA? Was polyneuropathy by age 1y attributed to the SUCLA2 mutation or interpreted as side effect of DCA? Was polyneuropathy a complication of diabetes?
Ketogenic diet has been shown to be highly beneficial for epilepsy, migraine, autism, or myopathy in single patients with a mitochondrial disorder (MID) [3] . Ketogenic diet may even improve cerebral lesions on MRI in Leigh syndrome [4] . Why was a ketogenic diet not applied to patient-1 but only to patient-2? Was ketogenic diet in patient-2 beneficial?
Patient-1 had normal cerebral MRI at age 3m and callosal thinning at age 7m. Why was no further MRI carried out during the next 13y despite obvious progression of cerebral involvement (Table 1) ?
Were bone fractures in both patients spontaneous or traumatic? Was a densitometry carried out? Which were the calcium, phosphate, and hormone levels in both patients? Was multiple hormone deficiency attributed to hypopituitarism? Was there a pituitary adenoma?
MID patients frequently develop cardiac disease, which may be subclinical at onset [5] . Which were the results of long-term ECG and echocardiography when actively searching for cardiac involvement?
Overall, this interesting study could be strengthened by reporting why DCA was given for 4y (patient-1), why no ketogenic diet was tried (patient-1), if there was a pituitary adenoma, and how cerebral involvement progressed on MRI (patient-1).
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